4//SEC Filing
Colangelo Dominick 4
Accession 0001140361-25-008820
CIK 0000887359other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:07 PM ET
Size
13.6 KB
Accession
0001140361-25-008820
Insider Transaction Report
Form 4
Vericel CorpVCEL
Colangelo Dominick
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-03-12$1.95/sh+26,591$51,852→ 286,588 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-12+26,591→ 26,592 totalExercise: $1.95→ Common Stock (26,591 underlying) - Sale
Common Stock
2025-03-12$46.31/sh−26,591$1,231,429→ 259,997 total - Exercise/Conversion
Common Stock
2025-03-13$1.95/sh+26,592$51,854→ 286,589 total - Sale
Common Stock
2025-03-13$45.78/sh−26,592$1,217,382→ 259,997 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-13+26,592→ 0 totalExercise: $1.95→ Common Stock (26,592 underlying)
Footnotes (4)
- [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024.
- [F3]These options, representing the right to purchase 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted.
- [F4]These options, which were awarded on February 9, 2016, would otherwise expire and become forfeitable on February 9, 2026.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001313403
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:07 PM ET
- Size
- 13.6 KB